Menu
Montecito
Pac Premier
Giving Guide
Loading...
You are here:  Home  >  'Amgen'  -  Page 12
Latest

Amgen warns investors of ‘mini-tender’ offer

By   /  Wednesday, October 23rd, 2019  /  Biotech, Latest news, Tri-County Public Companies  /  Comments Off on Amgen warns investors of ‘mini-tender’ offer

Biotech giant Amgen warned investors of a so-called “mini-tender” offer by TRC Capital Corp. that seeks to buy half a million of the company’s shares at below-market prices ahead of its third quarter earnings. The unsolicited offer is dated Oct. 11 and offers to purchase up to 500,000 of Amgen common stock at $192 per Read More →

Read More →
Latest

Amgen CFO retiring in 2020

By   /  Tuesday, October 22nd, 2019  /  Biotech, Central Coast Health Watch, East Ventura County, Latest news, Tri-County Public Companies  /  Comments Off on Amgen CFO retiring in 2020

This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.

Read More →
Latest

Amgen declares fourth-quarter dividend

By   /  Tuesday, October 22nd, 2019  /  Biotech, Earnings, East Ventura County, Latest news, Tri-County Public Companies  /  Comments Off on Amgen declares fourth-quarter dividend

This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.

Read More →
Latest

Amgen gets go-ahead on two drugs

By   /  Friday, October 18th, 2019  /  Latest news  /  Comments Off on Amgen gets go-ahead on two drugs

Regulators handed Amgen two victories for its drug portfolio, granting the Thousand Oaks biotech giant approval to treat a wider range of patients with osteoporosis and blood disorders. The U.S. Food and Drug Administration approved the use of Amgen’s immune thrombocytopenia drug Nplate for earlier use in adults Oct. 18, allowing it to be given Read More →

Read More →
Latest

Westlake Village BioPartners leads $85 million investment to fight cancer

By   /  Friday, October 18th, 2019  /  Latest news  /  Comments Off on Westlake Village BioPartners leads $85 million investment to fight cancer

This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.

Read More →
Latest

Tri-county biotech upstarts struggle to maintain stock prices

By   /  Friday, October 4th, 2019  /  Biotech, East Ventura County, right, Tri-County Public Companies  /  Comments Off on Tri-county biotech upstarts struggle to maintain stock prices

This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.

Read More →
Latest

Amgen trades cash for cash flow with Otezla deal

By   /  Friday, August 30th, 2019  /  Biotech, Central Coast Health Watch, East Ventura County, Top Stories, Top Story, Tri-County Public Companies  /  Comments Off on Amgen trades cash for cash flow with Otezla deal

Amgen’s $13.4 billion acquisition of lucrative psoriasis therapy Otezla secures nearly a decade of revenue growth for the biotech giant to bridge the gap between its waning legacy products and potential new contenders. The relatively small deal could nonetheless change the landscape of the biotech industry, allowing regulators to approve a $74 billion takeover bid Read More →

Read More →